ABBOTT NAMED ONE OF WORLD’S MOST INNOVATIVE COMPANIES

Thomson Reuters lists Abbott in the ‘Top 100’ for second consecutive year

Abbott was recently recognized as one of the world's most innovative companies, securing a spot on the Thomson Reuters 2014 Top 100 Global Innovators list for the second consecutive year.

This prestigious list, established in 2011, recognizes companies around the world for their outstanding commitment to innovation, the protection of ideas and the commercialization of inventions.

Recent examples of Abbott innovation:

• Abbott's FreeStyle^® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology launched in Europe for people with diabetes
• Abbott’s TECNIS^® Symfony Extended Range of Vision intraocular lens, a first-of-its-kind lens used in cataract treatment in Europe to provide clear vision at all distances
• Abbott’s Supera^® Peripheral Stent System, a treatment for blocked blood vessels in the upper leg caused by peripheral artery disease
• Abbott’s IRIDICA (currently in development), an innovative testing platform designed to identify infections within hours versus days

The Top 100 Global Innovators list, an initiative of the IP Solutions business of Thomson Reuters, honors the 100 corporations and institutions around the world that are at the heart of innovation, as measured by a series of proprietary patent-related metrics. The full report and related methodology is available at http://www.top100innovators.com.